Intersect ENT Competitors and Similar CompaniesClear all
Stryker's competitors and similar companies include Regeneron Pharmaceuticals and OptiNose.
 Stryker Stryker is a company that develops medical, surgical, neurotechnology, orthopedics, and spine products. |  Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines. | ||
Founding Date | Founding Date 1941 | Founding Date 1988 | Founding Date 2000 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more | Locations Morrisville, US HQ Oslo, NO Swindon, GB | |
Employees | Employees 53,0002% increase | Employees 15,1068% increase | Employees 2048% decrease |
Valuation ($) | Valuation ($) 135 b | Valuation ($) 102.2 b | Valuation ($) 118.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) $25.1b (FY, 2025) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $78.2m (FY, 2024) |
Cost of goods | Cost of goods $9.1b (FY, 2025) | Cost of goods N/A | Cost of goods $7.2m (FY, 2024) |
Gross profit | Gross profit $16.1b (FY, 2025) | Gross profit N/A | Gross profit $71m (FY, 2024) |
Net income | Net income $3.2b (FY, 2025) | Net income $4.5b (FY, 2025) | Net income ($21.5m) (FY, 2024) |
Operating ⚠ | |||
Patents (US) | Patents (US) N/A | Patents (US) 31 (FY, 2020) | Patents (US) 43 (Jun, 2017) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 53.9m | Total funding raised $ 120.5m |
For sources of this data, please see the company profile
View Company Profiles
Regeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
15,106↑ 8% increase
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
View company
OptiNose
HQ
Morrisville, US
Employees
204↓ 8% decrease
OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
View company